The LEGACy study: a European and Latin American consortium to identify risk factors and molecular phenotypes in gastric cancer to improve prevention strategies and personalized clinical decision making globally

BACKGROUND: Gastric Cancer (GC) is the fourth most deadly cancer worldwide. Enhanced understanding of its key epidemiological and molecular drivers is urgently needed to lower the incidence and improve outcomes. Furthermore, tumor biology in European (EU) and Latin American (LATAM) countries is unde...

Descripción completa

Detalles Bibliográficos
Autores principales: van Schooten, Tessa Suzanne, Derks, Sarah, Jiménez-Martí, Elena, Carneiro, Fatima, Figueiredo, Ceu, Ruiz, Erika, Alsina, Maria, Molero, Cristina, Garrido, Marcelo, Riquelme, Arnoldo, Caballero, Carmelo, Lezcano, Eva, O’Connor, Juan Manuel, Esteso, Federico, Farrés, Judith, Mas, José Manuel, Lordick, Florian, Vogt, Jeannette, Cardone, Antonella, Girvalaki, Charis, Cervantes, Andrés, Fleitas, Tania
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Study Protocol
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9190072/
https://www.ncbi.nlm.nih.gov/pubmed/35692051
http://dx.doi.org/10.1186/s12885-022-09689-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9190072/
https://www.ncbi.nlm.nih.gov/pubmed/35692051
http://dx.doi.org/10.1186/s12885-022-09689-9

Ejemplares similares